Cori Clinical, a London-based startup that acts as the #intelligence layer to accelerate #clinical#trials, has closed a €3.56 million Seed round. 🇬🇧 🧬 ⏱️
Glasgow-based @mironidltd, a #biopharmaceutical company, has closed a €39.9 million Series B round to push its lead drug candidate for Autosomal Dominant Polycystic #Kidney#Disease through #clinical development. 🏴 💊 💉
